2nd Quarter - Report

NOVOCURE INC. for NOVOCURE INC.

Firm
Client
Income
—
Expenses
$120,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

General Medicare / Medicaid Issues. H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021.

LobbyistCovered position, as disclosed
EMILY HAAS New Senior Policy Advisor, Congressman Conor Lamb; Legislative Aide for Congresswoman Allyson Schwartz
KATHERINE MEYER Senior Policy Advisor, Office of House Republican Leader Kevin McCarthy; Deputy Health Policy Director, Senate Finance Committee; Health Policy Advisor, Senator Orrin Hatch; Sr. LA, Congressman Erik Paulsen; LA, Congressman Jeff Fortenberry

Contacted: Office of Science & Technology Policy (OSTP); SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 4043 (117th)

Veterans VET

Veteran Affairs Issues.

LobbyistCovered position, as disclosed
EMILY HAAS —
KATHERINE MEYER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.